Skip to content
Home/Companies/Biotech/Isarna
Isarna

Isarna

Biotech·Germany·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns Isarna?

Isarna is currently owned by Sobera Capital through S-Refit AG (2016 vintage), since 2016.

Hand-verified · updated 2026-08-10

Sobera Capital
Investor
Sobera Capital
S-Refit AG · 2016 · Secondaries

Key facts

HQGermany
SectorBiotech
StatusActive
Websiteisarna-therapeutics.com

More from S-Refit AG

Other portfolio companies in the same fund.

Amicra
Exited 2018
Deep TechGermany· 2016
to
BioMAX
Exited 2022
HealthTechGermany· 2016
to
Curadis
Active
BiotechGermany· 2016
EnOcean
EnOcean
Exited 2024
Deep TechGermany· 2016
to
ERS electronic
Exited 2023
IndustrialsGermany· 2016
to
knowis
knowis
Active
SoftwareGermany· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Isarna

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Isarna?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Isarna.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue